File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1124/jpet.104.077990
- Scopus: eid_2-s2.0-14344263790
- PMID: 15550571
- WOS: WOS:000227008800046
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Raloxifene relaxes rat pulmonary arteries and veins: Roles of gender, endothelium, and antagonism of Ca2+ influx
Title | Raloxifene relaxes rat pulmonary arteries and veins: Roles of gender, endothelium, and antagonism of Ca2+ influx |
---|---|
Authors | |
Issue Date | 2005 |
Publisher | American Society for Pharmacology and Experimental Therapeutics. The Journal's web site is located at http://jpet.aspetjournals.org |
Citation | Journal Of Pharmacology And Experimental Therapeutics, 2005, v. 312 n. 3, p. 1266-1271 How to Cite? |
Abstract | Effects of raloxifene have been documented in the systemic circulation. However, its impact on the pulmonary circulation is unclear. The present study investigated the role of gender, endothelial modulation, and Ca2+ channel in relaxations evoked by raloxifene in rat pulmonary arteries and veins. Vascular responses were studied on isolated pulmonary blood vessels mounted in a myograph and constricted by U46619 (9,11-dideoxy-11α,9α- epoxymethanoprostaglandin F2α). Constrictions to CaCl 2 were studied in Ca2+-free, 60 mM K+ solution. Changes in the intracellular calcium ion concentration ([Ca2+] i) in vascular smooth muscle were measured using a calcium fluorescence imaging method. Raloxifene was more effective in relaxing U46619-constricted pulmonary arteries from male than female rats. Raloxifene-induced relaxation was unaffected by ICI 182,780 [7α-[9-[(4,4, 5,5,5,-pentafluoropentyl)-sulfinyl]nonyl]-estra-1,3,5(10)-triene-3, 17β-diol], inhibition of the nitric oxide (NO) pathway, or removal of the endothelium. In arteries without endothelium, raloxifene attenuated CaCl 2-induced constriction and CaCl2-stimulated increase in [Ca2+]i with similar potencies. Raloxifene caused endothelium-independent relaxations in pulmonary veins, albeit to a lesser degree than in pulmonary arteries. The venous responses showed a gender difference because raloxifene was more potent in male veins. In summary, raloxifene relaxed rat pulmonary arteries, and this effect did not involve the endothelium/NO or ICI 182,780-sensitive estrogen receptors. Raloxifene, like nifedipine, reduced constriction and [Ca2+]i increase in response to CaCl2 in high K+ solution. Raloxifene also relaxed high K+-constricted pulmonary veins. Our data indicate that raloxifene acutely relaxes rat pulmonary blood vessels primarily via inhibition of Ca2+ influx through voltage-sensitive Ca2+ channels. Finally, raloxifene induced more relaxation in blood vessels isolated from male than female rats. Copyright © 2005 by The American Society for Pharmacology and Experimental Therapeutics. |
Persistent Identifier | http://hdl.handle.net/10722/134682 |
ISSN | 2023 Impact Factor: 3.1 2023 SCImago Journal Rankings: 0.829 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, YC | en_HK |
dc.contributor.author | Leung, FP | en_HK |
dc.contributor.author | Yao, X | en_HK |
dc.contributor.author | Lau, CW | en_HK |
dc.contributor.author | Vanhoutte, PM | en_HK |
dc.contributor.author | Huang, Y | en_HK |
dc.date.accessioned | 2011-07-05T08:24:18Z | - |
dc.date.available | 2011-07-05T08:24:18Z | - |
dc.date.issued | 2005 | en_HK |
dc.identifier.citation | Journal Of Pharmacology And Experimental Therapeutics, 2005, v. 312 n. 3, p. 1266-1271 | en_HK |
dc.identifier.issn | 0022-3565 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/134682 | - |
dc.description.abstract | Effects of raloxifene have been documented in the systemic circulation. However, its impact on the pulmonary circulation is unclear. The present study investigated the role of gender, endothelial modulation, and Ca2+ channel in relaxations evoked by raloxifene in rat pulmonary arteries and veins. Vascular responses were studied on isolated pulmonary blood vessels mounted in a myograph and constricted by U46619 (9,11-dideoxy-11α,9α- epoxymethanoprostaglandin F2α). Constrictions to CaCl 2 were studied in Ca2+-free, 60 mM K+ solution. Changes in the intracellular calcium ion concentration ([Ca2+] i) in vascular smooth muscle were measured using a calcium fluorescence imaging method. Raloxifene was more effective in relaxing U46619-constricted pulmonary arteries from male than female rats. Raloxifene-induced relaxation was unaffected by ICI 182,780 [7α-[9-[(4,4, 5,5,5,-pentafluoropentyl)-sulfinyl]nonyl]-estra-1,3,5(10)-triene-3, 17β-diol], inhibition of the nitric oxide (NO) pathway, or removal of the endothelium. In arteries without endothelium, raloxifene attenuated CaCl 2-induced constriction and CaCl2-stimulated increase in [Ca2+]i with similar potencies. Raloxifene caused endothelium-independent relaxations in pulmonary veins, albeit to a lesser degree than in pulmonary arteries. The venous responses showed a gender difference because raloxifene was more potent in male veins. In summary, raloxifene relaxed rat pulmonary arteries, and this effect did not involve the endothelium/NO or ICI 182,780-sensitive estrogen receptors. Raloxifene, like nifedipine, reduced constriction and [Ca2+]i increase in response to CaCl2 in high K+ solution. Raloxifene also relaxed high K+-constricted pulmonary veins. Our data indicate that raloxifene acutely relaxes rat pulmonary blood vessels primarily via inhibition of Ca2+ influx through voltage-sensitive Ca2+ channels. Finally, raloxifene induced more relaxation in blood vessels isolated from male than female rats. Copyright © 2005 by The American Society for Pharmacology and Experimental Therapeutics. | en_HK |
dc.language | eng | en_US |
dc.publisher | American Society for Pharmacology and Experimental Therapeutics. The Journal's web site is located at http://jpet.aspetjournals.org | en_HK |
dc.relation.ispartof | Journal of Pharmacology and Experimental Therapeutics | en_HK |
dc.subject.mesh | Animals | en_HK |
dc.subject.mesh | Calcium - metabolism | en_HK |
dc.subject.mesh | Calcium Channels, L-Type - physiology | en_HK |
dc.subject.mesh | Dose-Response Relationship, Drug | en_HK |
dc.subject.mesh | Endothelium, Vascular - physiology | en_HK |
dc.subject.mesh | Estradiol - analogs & derivatives - pharmacology | en_HK |
dc.subject.mesh | Female | en_HK |
dc.subject.mesh | Male | en_HK |
dc.subject.mesh | Pulmonary Artery - drug effects - physiology | en_HK |
dc.subject.mesh | Pulmonary Veins - drug effects - physiology | en_HK |
dc.subject.mesh | Raloxifene - pharmacology | en_HK |
dc.subject.mesh | Rats | en_HK |
dc.subject.mesh | Rats, Sprague-Dawley | en_HK |
dc.subject.mesh | Selective Estrogen Receptor Modulators - pharmacology | en_HK |
dc.subject.mesh | Sex Characteristics | en_HK |
dc.subject.mesh | Vasodilation - drug effects | en_HK |
dc.title | Raloxifene relaxes rat pulmonary arteries and veins: Roles of gender, endothelium, and antagonism of Ca2+ influx | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Chan, YC:yauchi@graduate.hku.hk | en_US |
dc.identifier.authority | Chan, YC=rp01502 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1124/jpet.104.077990 | en_HK |
dc.identifier.pmid | 15550571 | - |
dc.identifier.scopus | eid_2-s2.0-14344263790 | en_HK |
dc.identifier.hkuros | 155342 | - |
dc.identifier.hkuros | 136333 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-14344263790&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 312 | en_HK |
dc.identifier.issue | 3 | en_HK |
dc.identifier.spage | 1266 | en_HK |
dc.identifier.epage | 1271 | en_HK |
dc.identifier.isi | WOS:000227008800046 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Chan, YC=7403676116 | - |
dc.identifier.scopusauthorid | Leung, FP=8615375300 | - |
dc.identifier.scopusauthorid | Yao, X=7402529434 | - |
dc.identifier.scopusauthorid | Lau, CW=7401968520 | - |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | - |
dc.identifier.scopusauthorid | Huang, Y=7501573013 | - |
dc.identifier.issnl | 0022-3565 | - |